Llama antibodies could help fight SARS-CoV-2 variants
On Dec. 7, 2021, Rockefeller University scientists announced a study had demonstrated the therapeutic potential of an unusual…
CDC launched two global networks, awarded $22 million to combat antimicrobial resistance and infectious diseases
On Dec. 7, 2021, the Centers for Disease Control and Prevention announced that it had awarded $22 million…
USAID announced Initiative for Global Vaccine Access to accelerate vaccine access and delivery around the world
On Dec. 6, 2021, the USAID announced the foundation of a new whole-of-government effort, the Initiative for Global…
Roche announced the launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark
On Dec. 6, 2021, Roche announced that its planned to launch the SARS-CoV-2 & Flu A/B Rapid Antigen…
CHMP recommended EU approval of Actemra/RoActemra to treat patients with severe COVID-19
On Dec. 6, 2021, Roche announced that the European Medicines Agencyï¾’s Committee for Medicinal Products for Human Use…
WHO advised against use of convalescent plasma for covid-19
On Dec. 6, 2021, the World Health Organization Guideline Development Group of international experts announced in the BMJ…
Sorrento announced publication of novel SARS-CoV-2 main protease inhibitors for potential treatment of COVID-19 patients infected with SARS-CoV-2
On Dec. 5, 2021, Sorrento Therapeutics announced the peer-reviewed publication of a series of novel SARS-CoV-2 MPro inhibitors…
Johnson & Johnson COVID-19 booster showed substantial increase in antibody and T-cell responses
On Dec. 5, 2021, Johnson & Johnson announced preliminary results from an independent study, including a subset of…
Genomics England sets out vision for newborn genomes research pilot
On Dec. 3, 2021, Genomics England has announced its vision for a pilot research project to examine the…
Roche announced additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant
On Dec. 3, 2021, Roche and TIB Molbiol announced they had added three additional Research Use Only test…
Gavi approved malaria vaccine programme funding
On Dec. 3, 2021, Gavi, the Vaccine Alliance, approved a new malaria vaccination programme to support the introduction,…
HHS study showed 63-fold increase in Medicare Telehealthutilization during the Pandemic
On Dec. 3, 2021, a report from the U.S. Department of Health and Human Services (HHS) found that…
NIH scientists discovered new B cell that tempers autoimmunity
On Dec. 2, 2021, researchers at the National Eye Institute (NEI) announced they had identified, isolated, and characterized…
Resilience and Harvard University announced five-year R&D alliance to incubate new technologies
On Dec. 2, 2021, National Resilience and Harvard University announed they had established a five-year research and development…
T2 Biosystems T2SARS-CoV-2 panel detected Omicron variant
On Dec. 1, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel detected the Omicron COVID-19 variant (B.1.1.529). To…
Fulgent Genetics confirmed ability to detect Omicron variant with RT-PCR tests for COVID-19
On Dec. 1, 2021, Fulgent Genetics confirmed that the Companyï¾’s RT-PCR test for SARS-CoV-2, the virus that causes…
Moderna announced supply agreement with the UK for additional 60 million doses of COVID-19 vaccine in 2022 and 2023
On Dec. 1, 2021, Moderna announced a revised supply agreement with the UK government for up to 60…
SIGA announced Health Canada regulatory approval of Oral TPOXX
On Dec. 1, 2021, SIGA Technologies announced that Health Canada had approved oral TPOXX (tecovirimat) as an extraordinary…
First confirmed case of Omicron variant detected in the United States
On Dec. 1, 2021, the California and San Francisco Departments of Public Health confirmed that a recent case…
Labcorp announced collection for COVID-19 PCR testing in over 500 Locations nationwide, with plans to double locations
On Nov. 30, 2021, LabCorp announced that it had begun offering observed self-collection for COVID-19 PCR testing in…
Thermo Fisher Scientific confirmed detection of SARS-CoV-2 in samples containing Omicron Variant with TaqPath COVID-19 tests
On Nov. 29, 2021, Thermo Fisher Scientific confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit…
Hologicï¾’s COVID-19 tests detected Omicron variant
On Nov. 29, 2021, Hologic announced that its three SARS-CoV-2 tests all detected the recently emerged Omicron variant…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Life Science History | Medicine | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 roller coaster
The COVID-19 Roller Coaster is a wild ride, strap yourself in and hold on… Cast of Characters: Senator…
Merck and Ridgeback Biotherapeutics provided update on results from MOVe-OUT study of Molnupiravir in adults with COVID-19
On Nov. 26, 2021, Merck provided an update on the MOVe-OUT study of molnupiravir, an investigational oral antiviral…
WHO announced classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern
On Nov. 26, 2021, the World Health Organization announced that the Technical Advisory Group on SARS-CoV-2 Virus Evolution…
Pfizer and BioNTech received positive CHMP opinion for COMIRNATYï¾® in children 5 to under 12 years of age in the EU
On Nov. 25, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
Novavax filed for interim authorization of COVID-19 vaccine in singapore
On Nov. 24, 2021, Novavax announced its submission to the Singapore Health Sciences Authority for interim authorization of…
Johnson & Johnson COVID-19 vaccine fully approved by Health Canada to prevent COVID-19 in ages 18 years and older
On Nov. 24, 2021, Johnson & Johnson announced the U.S. Food and Drug Administration had issued Emergency Use…
WHO and Medicines Patent Pool announced first transparent, global, non-exclusive licence for COVID-19 technology
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
Oxitec successfully concluded mosquito releases in landmark Florida Keys pilot program
On Nov. 23, 2021, Oxitec announced the successful completion of the mosquito release phase of its landmark project…